These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10706739)

  • 1. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
    Lopalco L; Barassi C; Pastori C; Longhi R; Burastero SE; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi AG
    J Immunol; 2000 Mar; 164(6):3426-33. PubMed ID: 10706739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural antibodies to CCR5 from breast milk block infection of macrophages and dendritic cells with primary R5-tropic HIV-1.
    Bouhlal H; Latry V; Requena M; Aubry S; Kaveri SV; Kazatchkine MD; Belec L; Hocini H
    J Immunol; 2005 Jun; 174(11):7202-9. PubMed ID: 15905565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1.
    Bouhlal H; Hocini H; Quillent-Grégoire C; Donkova V; Rose S; Amara A; Longhi R; Haeffner-Cavaillon N; Beretta A; Kaveri SV; Kazatchkine MD
    J Immunol; 2001 Jun; 166(12):7606-11. PubMed ID: 11390517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.
    Montefiori DC; Collman RG; Fouts TR; Zhou JY; Bilska M; Hoxie JA; Moore JP; Bolognesi DP
    J Virol; 1998 Mar; 72(3):1886-93. PubMed ID: 9499040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
    Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L
    AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.
    Eslahpazir J; Jenabian MA; Bouhlal H; Hocini H; Carbonneil C; Grésenguet G; Mbopi Kéou FX; LeGoff J; Saïdi H; Requena M; Nasreddine N; de Dieu Longo J; Kaveri SV; Bélec L
    Clin Vaccine Immunol; 2008 May; 15(5):872-84. PubMed ID: 18353923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new prospective against HIV infection: induction of murin CCR5-downregulating antibodies.
    Barassi C; Marenzi C; Pastori C; Longhi R; Lazzarin A; Lopalco L
    New Microbiol; 2004 Apr; 27(2 Suppl 1):85-94. PubMed ID: 15646069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes.
    Hornung F; Scala G; Lenardo MJ
    J Immunol; 2000 Jun; 164(12):6180-7. PubMed ID: 10843668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity.
    Lehner T; Doyle C; Wang Y; Babaahmady K; Whittall T; Tao L; Bergmeier L; Kelly C
    J Immunol; 2001 Jun; 166(12):7446-55. PubMed ID: 11390497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.
    Barassi C; Soprana E; Pastori C; Longhi R; Buratti E; Lillo F; Marenzi C; Lazzarin A; Siccardi AG; Lopalco L
    J Virol; 2005 Jun; 79(11):6848-58. PubMed ID: 15890924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
    Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
    Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.
    Lopalco L; Pastori C; Cosma A; Burastero SE; Capiluppi B; Boeri E; Beretta A; Lazzarin A; Siccardi AG
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):109-15. PubMed ID: 10659050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
    Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
    J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.
    Pastori C; Weiser B; Barassi C; Uberti-Foppa C; Ghezzi S; Longhi R; Calori G; Burger H; Kemal K; Poli G; Lazzarin A; Lopalco L
    Blood; 2006 Jun; 107(12):4825-33. PubMed ID: 16522810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
    Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
    J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project.
    Clerici M; Butto S; Lukwiya M; Saresella M; Declich S; Trabattoni D; Pastori C; Piconi S; Fracasso C; Fabiani M; Ferrante P; Rizzardini G; Lopalco L
    AIDS; 2000 Sep; 14(14):2083-92. PubMed ID: 11061648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens.
    Pastori C; Clivio A; Diomede L; Consonni R; De Mori GM; Longhi R; Colombo G; Lopalco L
    J Virol; 2008 Apr; 82(8):4125-34. PubMed ID: 18256149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.
    Pastori C; Barassi C; Piconi S; Longhi R; Villa ML; Siccardi AG; Clerici M; Lopalco L
    J Biol Regul Homeost Agents; 2000; 14(1):15-21. PubMed ID: 10763886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.